Published in J Biol Chem on March 10, 2000
Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J (2001) 2.30
Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology (2002) 2.18
MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med (2012) 2.13
Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci U S A (2001) 1.66
Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J (2010) 1.36
Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J (2004) 1.32
Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett (2014) 1.29
The mitochondrial respiratory chain is a modulator of apoptosis. J Cell Biol (2007) 1.28
Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion (2013) 1.17
Expression of beta-F1-ATPase and mitochondrial transcription factor A and the change in mitochondrial DNA content in colorectal cancer: clinical data analysis and evidence from an in vitro study. Int J Colorectal Dis (2008) 1.16
Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress. J Biol Chem (2007) 1.16
A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling. J Biol Chem (2008) 1.10
PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations. Hum Mol Genet (2007) 1.07
Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress. Mol Biol Cell (2009) 1.04
Systems biology approach to identification of biomarkers for metastatic progression in cancer. BMC Bioinformatics (2008) 1.04
Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2. Mol Biol Cell (2010) 1.00
Lack of cytochrome c in mouse fibroblasts disrupts assembly/stability of respiratory complexes I and IV. J Biol Chem (2008) 0.98
Role of cytochrome C in apoptosis: increased sensitivity to tumor necrosis factor alpha is associated with respiratory defects but not with lack of cytochrome C release. Mol Cell Biol (2007) 0.97
Alterations of the mitochondrial proteome caused by the absence of mitochondrial DNA: A proteomic view. Electrophoresis (2006) 0.95
Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J Biol Chem (2011) 0.95
Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species. Oncotarget (2016) 0.93
Role of calcineurin, hnRNPA2 and Akt in mitochondrial respiratory stress-mediated transcription activation of nuclear gene targets. Biochim Biophys Acta (2010) 0.93
Restoration of mitochondria function as a target for cancer therapy. Drug Discov Today (2015) 0.93
A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer. J Bioenerg Biomembr (2007) 0.90
Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels. Mol Oncol (2011) 0.90
Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Oncogenesis (2013) 0.89
Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model. PLoS One (2015) 0.89
Putative role of adipose tissue in growth and metabolism of colon cancer cells. Front Oncol (2014) 0.87
Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes. Mol Biol Cell (2004) 0.87
Role of insulin receptor and balance in insulin receptor isoforms A and B in regulation of apoptosis in simian virus 40-immortalized neonatal hepatocytes. Mol Biol Cell (2008) 0.85
Radiation response and regulation of apoptosis induced by a combination of TRAIL and CHX in cells lacking mitochondrial DNA: a role for NF-κB-STAT3-directed gene expression. Exp Cell Res (2011) 0.85
In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning. EMBO J (2014) 0.82
Impaired mitochondrial metabolism and mammary carcinogenesis. J Mammary Gland Biol Neoplasia (2012) 0.82
Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents. Cell Death Dis (2015) 0.81
Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state. Oncotarget (2016) 0.81
A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma. J Cell Biochem (2012) 0.81
Proteomic analysis on N, N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells. BMC Biochem (2012) 0.81
An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression. Mol Cells (2012) 0.80
Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models. BMC Med Genomics (2008) 0.80
Mitochondrial dysfunction-mediated apoptosis resistance associates with defective heat shock protein response in African-American men with prostate cancer. Br J Cancer (2016) 0.79
Pathomechanisms in coenzyme q10-deficient human fibroblasts. Mol Syndromol (2014) 0.79
Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway. Cell Death Dis (2014) 0.79
Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7. Evid Based Complement Alternat Med (2015) 0.79
Deregulation of mitochondrial ATPsyn-β in acute myeloid leukemia cells and with increased drug resistance. PLoS One (2013) 0.78
The globular heads of the C1q receptor regulate apoptosis in human cervical squamous carcinoma cells via a p53-dependent pathway. J Transl Med (2012) 0.77
Identification of the miRNA-mRNA regulatory network of small cell osteosarcoma based on RNA-seq. Oncotarget (2017) 0.77
Proteomic profiling of mitochondria: what does it tell us about the ageing brain? Aging (Albany NY) (2016) 0.75
Coating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy against Leishmania in hamsters by inducing Th1-type immune responses. Br J Pharmacol (2014) 0.75
Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy. Br J Pharmacol (2015) 0.75
Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology (1988) 4.28
A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science (1989) 3.02
MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol (1992) 2.48
Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res (1990) 2.28
Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res (2000) 2.26
Cytochrome c oxidase assembly in primates is sensitive to small evolutionary variations in amino acid sequence. Mol Biol Evol (2000) 2.19
Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet (1994) 2.16
Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet (1991) 2.10
Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology (1990) 1.97
An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol (2000) 1.95
Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem (1999) 1.92
Mitochondrial encephalomyopathies. Arch Neurol (1993) 1.79
Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol (2001) 1.53
Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. Am J Hum Genet (1990) 1.40
Human xenomitochondrial cybrids. Cellular models of mitochondrial complex I deficiency. J Biol Chem (1998) 1.38
Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Hum Mol Genet (2001) 1.32
Expanding the functional human mitochondrial DNA database by the establishment of primate xenomitochondrial cybrids. Proc Natl Acad Sci U S A (1997) 1.31
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res (1997) 1.19
Suppression of a mitochondrial tRNA gene mutation phenotype associated with changes in the nuclear background. Hum Mol Genet (1999) 1.17
A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet (1992) 1.16
Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet (1994) 1.15
Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology (2002) 1.14
Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients. Am J Pathol (1988) 1.14
Functional constraints of nuclear-mitochondrial DNA interactions in xenomitochondrial rodent cell lines. J Biol Chem (2000) 1.13
Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet (1995) 1.12
Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology (1992) 1.10
Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Gut (2007) 1.09
Cloning of an endangered species (Bos gaurus) using interspecies nuclear transfer. Cloning (2000) 1.09
The mitochondrial tRNA(Leu)(UUR)) mutation in MELAS: a model for pathogenesis. Biochim Biophys Acta (1992) 1.08
A disease-associated G5703A mutation in human mitochondrial DNA causes a conformational change and a marked decrease in steady-state levels of mitochondrial tRNA(Asn). Mol Cell Biol (1997) 1.08
Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease. Gene Ther (2010) 1.06
Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. J Biol Chem (1990) 1.06
Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease. Gene Ther (2011) 1.04
A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord (1995) 1.04
Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model. Gene Ther (2007) 1.02
New morphological approaches to the study of mitochondrial encephalomyopathies. Brain Pathol (1992) 0.95
Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs. Biochem Pharmacol (2000) 0.89
High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. Neurology (1995) 0.88
Clinical and morphologic features of a myopathy associated with a point mutation in the mitochondrial tRNA(Pro) gene. Neurology (1994) 0.88
Mitochondrial encephalomyopathies. Neurol Clin (1990) 0.88
Identification of a mutation in the mitochondrial tRNA(Cys) gene associated with mitochondrial encephalopathy. Hum Mutat (1996) 0.87
Deletions of mitochondrial DNA in Kearns-Sayre syndrome. 1988. Neurology (1998) 0.87
Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol (1991) 0.87
Structural and functional mitochondrial abnormalities associated with high levels of partially deleted mitochondrial DNAs in somatic cell hybrids. Somat Cell Mol Genet (1992) 0.86
Disorders associated with depletion of mitochondrial DNA. Brain Pathol (1992) 0.84
Detection and analysis of mitochondrial DNA deletions by whole genome PCR. Biochem Mol Med (1996) 0.84
A MERRF/PEO overlap syndrome associated with the mitochondrial DNA 3243 mutation. Neurology (1996) 0.83
Oxidative phosphorylation dysfunction does not increase the rate of accumulation of age-related mtDNA deletions in skeletal muscle. Mutat Res (1997) 0.82
Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. J Clin Endocrinol Metab (1999) 0.81
Isolation and characterization of a heparin with high anticoagulant activity from Anomalocardia brasiliana. Biochim Biophys Acta (1985) 0.81
Dopamine transporter mRNA in autopsy studies of chronic cocaine users. Brain Res Mol Brain Res (1999) 0.81
Mitochondrial DNA defects in Brazilian patients with chronic progressive external ophthalmoplegia. J Neurol Sci (1997) 0.80
Duplication and triplication with staggered breakpoints in human mitochondrial DNA. Biochim Biophys Acta (1998) 0.80
Dysfunctional mitochondrial respiration in the wobbler mouse brain. Neurosci Lett (2001) 0.79
A helicase is born. Nat Genet (2001) 0.79
A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res (1997) 0.79
Mitochondrial encephalomyopathies: biochemical approach. Rev Neurol (Paris) (1991) 0.78
Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins. Cell Mol Biol (Noisy-le-grand) (1998) 0.78
Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology (1998) 0.78
Simultaneous transfer of mitochondrial DNA and single chromosomes in somatic cells: a novel approach for the study of defects in nuclear-mitochondrial communication. Hum Mol Genet (1998) 0.77
Functional and structural features of a tandem duplication of the human mtDNA promoter region. Am J Hum Genet (1997) 0.77
Mitochondrial encephalomyopathy and hypoparathyroidism associated with a duplication and a deletion of mitochondrial deoxyribonucleic acid. J Clin Endocrinol Metab (1998) 0.76
A novel myopathy-associated mitochondrial DNA mutation altering the conserved size of the tRNA(Gln) anticodon loop. Neuromuscul Disord (2000) 0.75
Sequencing of heparan sulfate proteoglycans: identification of variable and constant oligosaccharide regions in eight heparan sulfate proteoglycans of different origins. Braz J Med Biol Res (1994) 0.75
Mitochondrial encephalomyopathies. Prog Clin Biol Res (1989) 0.75
Clinical and biochemical studies on cytochrome oxidase deficiencies. Ann N Y Acad Sci (1988) 0.75
Mitochondrial dysfunction as a mechanism of CNS injury. Res Publ Assoc Res Nerv Ment Dis (1993) 0.75